Sales and Marketing

Showing 15 posts of 11526 posts found.

Cimzia results excite UCB in psoriatic arthritis

February 16, 2012 Research and Development, Sales and Marketing Cimzia, UCB, psoriatic arthritis

UCB will submit Cimzia for psoriatic arthritis by the end of 2012, after positive Phase III trial results for the …

Panu Miettinen appointed chief financial officer of Biotie

February 16, 2012 Business Services, Research and Development, Sales and Marketing Biotie, Panu Miettinen

Panu Miettinen, 43, has been appointed chief financial officer of Biotie Therapies.  He will become a member of the Group’s …
lucverhelst

EMA appoints new head of information and communications technology

February 16, 2012 Business Services, Medical Communications, Sales and Marketing EMA, Luc Verhelst

Luc Verhelst has been appointed as the new head of the European Medicines Agency’s information and communications technology unit. Verhelst …

NICE frowns on Botox for headache prevention

February 16, 2012 Sales and Marketing Allergan, Botox, EMA, NHS, NICE

NICE is not recommending Allergan’s Botox for headache prevention, and has asked the firm for more information on the drug.  …

Amgen appoints Michael Severino as senior vice president, Global Development and Corporate chief medical officer

February 16, 2012 Business Services, Research and Development, Sales and Marketing

Michael Severino has been named senior vice president, Global Development and Corporate chief medical officer at Amgen.Severino, 46, formerly vice president, …
Teva image

Teva launches generic Aricept in the UK

February 16, 2012 Manufacturing and Production, Sales and Marketing Alzheimer's, Aricept, NHS, Pfizer, Teva

Teva has launched its generic version of Alzheimer’s drug Aricept, as the drug loses its patent protection in the UK.  …

Most patients happy with hospital care

February 15, 2012 Sales and Marketing NHS, hospital, patient survey

A new survey has found that the vast majority of NHS patients receiving outpatient hospital care are happy with the …
Pfizer picture

FDA accepts Pfizer rare disease drug for review

February 15, 2012 Sales and Marketing EMA, FDA, FoldRx, Pfizer, tafamidis meglumine

The FDA has accepted for review Pfizer’s new drug to treat a rare neurodegenerative disease. Pfizer is seeking a licence …
Novo Nordisk image

Diabetes – the battle for control

February 15, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Novo Nordisk, Sanofi, Victoza, degludec, diabetes

This year marks the 90th anniversary of the first ever successful use of insulin to treat patients with type I …

Strategic North appoints Paula Lashley as consultant

February 15, 2012 Business Services, Medical Communications, Sales and Marketing

Healthcare strategic marketing consultancy Strategic North, who recently reached the final of the Manchester Evening News Business of the Year …

Pharma critical of Obama budget

February 15, 2012 Research and Development, Sales and Marketing IPAB, Independent Payment Advisory Board, Medicare, Obama, PhRMA, US, healthcare reform

President Obama has unveiled a new budget which aims to cut the US deficit by $4 trillion over the next …
Biogen image

Biogen to pay $563 million for Stromedix

February 15, 2012 Research and Development, Sales and Marketing Bioden Idec, R&D, STX-100, Stromedix

Biogen Idec will acquire the specialist immunology firm Stromedix for around $500 million. Biogen currently focuses on the development of …

Ablynx appoints Dr Andreas Menrad as its new chief scientific officer

February 15, 2012 Business Services, Research and Development, Sales and Marketing Abllynx, Menrad, nanobody

Dr Andreas Menrad has joined the Belgium-based firm Ablynx as its new chief scientific officer. Dr Menrad has over 20 …

New PV Legislation Implementation Plan by the European Medicines Agency

February 14, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing wainwright associates; Pharmacovigilance legislation

The European Medicines Agency has released an implementation plan for the pharmacovigilance legislation, which sets out milestone dates for different …

Merck’s eye drug Zioptan gains FDA approval

February 14, 2012 Sales and Marketing Merck, Pfizer, Xalatan, Zioptan

The FDA has approved Merck’s eye solution Zioptan to treat a common eye condition. Zioptan (tafluprost ophthalmic solution) can now …
The Gateway to Local Adoption Series

Latest content